カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の新興がんワクチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Emerging Cancer Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19291）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19291
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の新興がんワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

新興がんワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の新興がんワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

新興がんワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・非遺伝子ワクチン、遺伝子ワクチン

用途別セグメントは次のように区分されます。
・がん研究所、がん病院、診療所、その他

世界の新興がんワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Antigenics、Avax Technologies、GlaxoSmithKline、Merck、Moderna、Northwest Biotherapeutics

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、新興がんワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な新興がんワクチンメーカーの企業概要、2019年～2022年までの新興がんワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な新興がんワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別新興がんワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの新興がんワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での新興がんワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および新興がんワクチンの産業チェーンを掲載しています。
・第13、14、15章では、新興がんワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 新興がんワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：非遺伝子ワクチン、遺伝子ワクチン
- 用途別分析（2017年vs2021年vs2028年）：がん研究所、がん病院、診療所、その他
- 世界の新興がんワクチン市場規模・予測
- 世界の新興がんワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Antigenics、Avax Technologies、GlaxoSmithKline、Merck、Moderna、Northwest Biotherapeutics
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：非遺伝子ワクチン、遺伝子ワクチン
・用途別分析2017年-2028年：がん研究所、がん病院、診療所、その他
・新興がんワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・新興がんワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・新興がんワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・新興がんワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・新興がんワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Emerging Cancer Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Emerging Cancer Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cancer Research Centers accounting for % of the Emerging Cancer Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Non Genetic Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Emerging Cancer Vaccines include Antigenics, Avax Technologies, GlaxoSmithKline, Merck, and Moderna, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Emerging Cancer Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Non Genetic Vaccines
Genetic Vaccines
Market segment by Application can be divided into
Cancer Research Centers
Cancer Hospital
Clinics
Others
The key market players for global Emerging Cancer Vaccines market are listed below:
Antigenics
Avax Technologies
GlaxoSmithKline
Merck
Moderna
Northwest Biotherapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Emerging Cancer Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Emerging Cancer Vaccines, with price, sales, revenue and global market share of Emerging Cancer Vaccines from 2019 to 2022.
Chapter 3, the Emerging Cancer Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Emerging Cancer Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Emerging Cancer Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Emerging Cancer Vaccines.
Chapter 13, 14, and 15, to describe Emerging Cancer Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Emerging Cancer Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Emerging Cancer Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Non Genetic Vaccines
1.2.3 Genetic Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Emerging Cancer Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer Research Centers
1.3.3 Cancer Hospital
1.3.4 Clinics
1.3.5 Others
1.4 Global Emerging Cancer Vaccines Market Size & Forecast
1.4.1 Global Emerging Cancer Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Emerging Cancer Vaccines Sales in Volume (2017-2028)
1.4.3 Global Emerging Cancer Vaccines Price (2017-2028)
1.5 Global Emerging Cancer Vaccines Production Capacity Analysis
1.5.1 Global Emerging Cancer Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Emerging Cancer Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Emerging Cancer Vaccines Market Drivers
1.6.2 Emerging Cancer Vaccines Market Restraints
1.6.3 Emerging Cancer Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Antigenics
2.1.1 Antigenics Details
2.1.2 Antigenics Major Business
2.1.3 Antigenics Emerging Cancer Vaccines Product and Services
2.1.4 Antigenics Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Avax Technologies
2.2.1 Avax Technologies Details
2.2.2 Avax Technologies Major Business
2.2.3 Avax Technologies Emerging Cancer Vaccines Product and Services
2.2.4 Avax Technologies Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Emerging Cancer Vaccines Product and Services
2.3.4 GlaxoSmithKline Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Emerging Cancer Vaccines Product and Services
2.4.4 Merck Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Moderna
2.5.1 Moderna Details
2.5.2 Moderna Major Business
2.5.3 Moderna Emerging Cancer Vaccines Product and Services
2.5.4 Moderna Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Northwest Biotherapeutics
2.6.1 Northwest Biotherapeutics Details
2.6.2 Northwest Biotherapeutics Major Business
2.6.3 Northwest Biotherapeutics Emerging Cancer Vaccines Product and Services
2.6.4 Northwest Biotherapeutics Emerging Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Emerging Cancer Vaccines Breakdown Data by Manufacturer
3.1 Global Emerging Cancer Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Emerging Cancer Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Emerging Cancer Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Emerging Cancer Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Emerging Cancer Vaccines Manufacturer Market Share in 2021
3.5 Global Emerging Cancer Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Emerging Cancer Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Emerging Cancer Vaccines Market Size by Region
4.1.1 Global Emerging Cancer Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Emerging Cancer Vaccines Revenue by Region (2017-2028)
4.2 North America Emerging Cancer Vaccines Revenue (2017-2028)
4.3 Europe Emerging Cancer Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Emerging Cancer Vaccines Revenue (2017-2028)
4.5 South America Emerging Cancer Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Emerging Cancer Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Emerging Cancer Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Emerging Cancer Vaccines Revenue by Type (2017-2028)
5.3 Global Emerging Cancer Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Emerging Cancer Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Emerging Cancer Vaccines Revenue by Application (2017-2028)
6.3 Global Emerging Cancer Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Emerging Cancer Vaccines Sales by Type (2017-2028)
7.2 North America Emerging Cancer Vaccines Sales by Application (2017-2028)
7.3 North America Emerging Cancer Vaccines Market Size by Country
7.3.1 North America Emerging Cancer Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Emerging Cancer Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Emerging Cancer Vaccines Sales by Type (2017-2028)
8.2 Europe Emerging Cancer Vaccines Sales by Application (2017-2028)
8.3 Europe Emerging Cancer Vaccines Market Size by Country
8.3.1 Europe Emerging Cancer Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Emerging Cancer Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Emerging Cancer Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Emerging Cancer Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Emerging Cancer Vaccines Market Size by Region
9.3.1 Asia-Pacific Emerging Cancer Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Emerging Cancer Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Emerging Cancer Vaccines Sales by Type (2017-2028)
10.2 South America Emerging Cancer Vaccines Sales by Application (2017-2028)
10.3 South America Emerging Cancer Vaccines Market Size by Country
10.3.1 South America Emerging Cancer Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Emerging Cancer Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Emerging Cancer Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Emerging Cancer Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Emerging Cancer Vaccines Market Size by Country
11.3.1 Middle East & Africa Emerging Cancer Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Emerging Cancer Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Emerging Cancer Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Emerging Cancer Vaccines
12.3 Emerging Cancer Vaccines Production Process
12.4 Emerging Cancer Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Emerging Cancer Vaccines Typical Distributors
13.3 Emerging Cancer Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Emerging Cancer Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Emerging Cancer Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Antigenics Basic Information, Manufacturing Base and Competitors
Table 4. Antigenics Major Business
Table 5. Antigenics Emerging Cancer Vaccines Product and Services
Table 6. Antigenics Emerging Cancer Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Avax Technologies Basic Information, Manufacturing Base and Competitors
Table 8. Avax Technologies Major Business
Table 9. Avax Technologies Emerging Cancer Vaccines Product and Services
Table 10. Avax Technologies Emerging Cancer Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Emerging Cancer Vaccines Product and Services
Table 14. GlaxoSmithKline Emerging Cancer Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Emerging Cancer Vaccines Product and Services
Table 18. Merck Emerging Cancer Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Moderna Basic Information, Manufacturing Base and Competitors
Table 20. Moderna Major Business
Table 21. Moderna Emerging Cancer Vaccines Product and Services
Table 22. Moderna Emerging Cancer Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Northwest Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Northwest Biotherapeutics Major Business
Table 25. Northwest Biotherapeutics Emerging Cancer Vaccines Product and Services
Table 26. Northwest Biotherapeutics Emerging Cancer Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Emerging Cancer Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Emerging Cancer Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Emerging Cancer Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Emerging Cancer Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Emerging Cancer Vaccines Production Site of Key Manufacturer
Table 32. Emerging Cancer Vaccines New Entrant and Capacity Expansion Plans
Table 33. Emerging Cancer Vaccines Mergers & Acquisitions in the Past Five Years
Table 34. Global Emerging Cancer Vaccines Sales by Region (2017-2022) & (K Units)
Table 35. Global Emerging Cancer Vaccines Sales by Region (2023-2028) & (K Units)
Table 36. Global Emerging Cancer Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Emerging Cancer Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units)
Table 39. Global Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units)
Table 40. Global Emerging Cancer Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Emerging Cancer Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Emerging Cancer Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 43. Global Emerging Cancer Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 44. Global Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units)
Table 45. Global Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units)
Table 46. Global Emerging Cancer Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Emerging Cancer Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Emerging Cancer Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 49. Global Emerging Cancer Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 50. North America Emerging Cancer Vaccines Sales by Country (2017-2022) & (K Units)
Table 51. North America Emerging Cancer Vaccines Sales by Country (2023-2028) & (K Units)
Table 52. North America Emerging Cancer Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Emerging Cancer Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. North America Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units)
Table 56. North America Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units)
Table 57. North America Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units)
Table 58. Europe Emerging Cancer Vaccines Sales by Country (2017-2022) & (K Units)
Table 59. Europe Emerging Cancer Vaccines Sales by Country (2023-2028) & (K Units)
Table 60. Europe Emerging Cancer Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Emerging Cancer Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units)
Table 63. Europe Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units)
Table 64. Europe Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units)
Table 65. Europe Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Emerging Cancer Vaccines Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Emerging Cancer Vaccines Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Emerging Cancer Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Emerging Cancer Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units)
Table 74. South America Emerging Cancer Vaccines Sales by Country (2017-2022) & (K Units)
Table 75. South America Emerging Cancer Vaccines Sales by Country (2023-2028) & (K Units)
Table 76. South America Emerging Cancer Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Emerging Cancer Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units)
Table 79. South America Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units)
Table 80. South America Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units)
Table 81. South America Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Emerging Cancer Vaccines Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Emerging Cancer Vaccines Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Emerging Cancer Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Emerging Cancer Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Emerging Cancer Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Emerging Cancer Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Emerging Cancer Vaccines Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Emerging Cancer Vaccines Sales by Application (2023-2028) & (K Units)
Table 90. Emerging Cancer Vaccines Raw Material
Table 91. Key Manufacturers of Emerging Cancer Vaccines Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Emerging Cancer Vaccines Typical Distributors
Table 95. Emerging Cancer Vaccines Typical Customers
List of Figures
Figure 1. Emerging Cancer Vaccines Picture
Figure 2. Global Emerging Cancer Vaccines Revenue Market Share by Type in 2021
Figure 3. Non Genetic Vaccines
Figure 4. Genetic Vaccines
Figure 5. Global Emerging Cancer Vaccines Revenue Market Share by Application in 2021
Figure 6. Cancer Research Centers
Figure 7. Cancer Hospital
Figure 8. Clinics
Figure 9. Others
Figure 10. Global Emerging Cancer Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Emerging Cancer Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Emerging Cancer Vaccines Sales (2017-2028) & (K Units)
Figure 13. Global Emerging Cancer Vaccines Price (2017-2028) & (USD/Unit)
Figure 14. Global Emerging Cancer Vaccines Production Capacity (2017-2028) & (K Units)
Figure 15. Global Emerging Cancer Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Emerging Cancer Vaccines Market Drivers
Figure 17. Emerging Cancer Vaccines Market Restraints
Figure 18. Emerging Cancer Vaccines Market Trends
Figure 19. Global Emerging Cancer Vaccines Sales Market Share by Manufacturer in 2021
Figure 20. Global Emerging Cancer Vaccines Revenue Market Share by Manufacturer in 2021
Figure 21. Emerging Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Emerging Cancer Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Emerging Cancer Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Emerging Cancer Vaccines Sales Market Share by Region (2017-2028)
Figure 25. Global Emerging Cancer Vaccines Revenue Market Share by Region (2017-2028)
Figure 26. North America Emerging Cancer Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Europe Emerging Cancer Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Emerging Cancer Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. South America Emerging Cancer Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Emerging Cancer Vaccines Revenue (2017-2028) & (USD Million)
Figure 31. Global Emerging Cancer Vaccines Sales Market Share by Type (2017-2028)
Figure 32. Global Emerging Cancer Vaccines Revenue Market Share by Type (2017-2028)
Figure 33. Global Emerging Cancer Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Emerging Cancer Vaccines Sales Market Share by Application (2017-2028)
Figure 35. Global Emerging Cancer Vaccines Revenue Market Share by Application (2017-2028)
Figure 36. Global Emerging Cancer Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Emerging Cancer Vaccines Sales Market Share by Type (2017-2028)
Figure 38. North America Emerging Cancer Vaccines Sales Market Share by Application (2017-2028)
Figure 39. North America Emerging Cancer Vaccines Sales Market Share by Country (2017-2028)
Figure 40. North America Emerging Cancer Vaccines Revenue Market Share by Country (2017-2028)
Figure 41. United States Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Emerging Cancer Vaccines Sales Market Share by Type (2017-2028)
Figure 45. Europe Emerging Cancer Vaccines Sales Market Share by Application (2017-2028)
Figure 46. Europe Emerging Cancer Vaccines Sales Market Share by Country (2017-2028)
Figure 47. Europe Emerging Cancer Vaccines Revenue Market Share by Country (2017-2028)
Figure 48. Germany Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Emerging Cancer Vaccines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Emerging Cancer Vaccines Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Emerging Cancer Vaccines Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Emerging Cancer Vaccines Revenue Market Share by Region (2017-2028)
Figure 57. China Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Emerging Cancer Vaccines Sales Market Share by Type (2017-2028)
Figure 64. South America Emerging Cancer Vaccines Sales Market Share by Application (2017-2028)
Figure 65. South America Emerging Cancer Vaccines Sales Market Share by Country (2017-2028)
Figure 66. South America Emerging Cancer Vaccines Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Emerging Cancer Vaccines Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Emerging Cancer Vaccines Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Emerging Cancer Vaccines Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Emerging Cancer Vaccines Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Emerging Cancer Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Emerging Cancer Vaccines in 2021
Figure 78. Manufacturing Process Analysis of Emerging Cancer Vaccines
Figure 79. Emerging Cancer Vaccines Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の小児ワクチン市場2022年：市場規模予測（～2028年）
  • 世界のウイルスベクターワクチン市場2022年：市場規模予測（～2028年）
  • 世界の不活化ポリオ＆狂犬病ワクチン市場2022年：市場規模予測（～2028年）
  • 世界の承認済みCOVID-19ワクチン市場2022年：市場規模予測（～2028年）
  • ポリオワクチンのグローバル市場展望 2023年-2029年：IPV、OPV
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19291 )"世界の新興がんワクチン市場2022年：市場規模予測（～2028年）" (英文：Global Emerging Cancer Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。